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CAPS Acts at a Prefusion Step in Dense-Core
Vesicle Exocytosis as a PIP2 Binding Protein
CAPS (Ca2-dependent activator protein for secre-
tion) was discovered as a neuron/endocrine-specific
150 kDa protein that reconstitutes Ca2-triggered DCV
Ruslan N. Grishanin,1 Judith A. Kowalchyk,1
Vadim A. Klenchin,1 Kyougsook Ann,1
Cynthia A. Earles,2 Edwin R. Chapman,2
Roy R.L. Gerona,1 and Thomas F.J. Martin1,* exocytosis in permeable neuroendocrine cells (Walent
1Department of Biochemistry et al., 1992; Hay and Martin, 1992; Ann et al., 1997). This
2 Department of Physiology is currently known as CAPS-1 because of the character-
University of Wisconsin ization of a second highly homologous and more ubiqui-
Madison, Wisconsin 53706 tously expressed CAPS-2 protein in higher vertebrates
(Speidel et al., 2003; Cisternas et al., 2003). Null mutants
in the single CAPS gene in C. elegans (Avery et al., 1993;
Summary Ann et al., 1997) and D. melanogaster (Renden et al.,
2001) exhibit loss of secretion of a subset of transmit-
CAPS-1 is required for Ca2-triggered fusion of dense- ters. Mammalian CAPS-1 is cytosolic as well as mem-
core vesicles with the plasma membrane, but its site brane-associated in neurons and localizes to the plasma
of action and mechanism are unknown. We analyzed membrane and to DCVs but not SVs (Berwin et al., 1998;
the kinetics of Ca2-triggered exocytosis reconstituted Grishanin et al., 2002). Neutralizing CAPS-1 antibodies
in permeable PC12 cells. CAPS-1 increased the initial disrupt DCV but not SV exocytosis (Berwin et al., 1998;
rate of Ca2-triggered vesicle exocytosis by acting at a Tandon et al., 1998; Elhamdani et al., 1999; Rupnik et
rate-limiting, Ca2-dependent prefusion step. CAPS-1 al., 2000; Olsen et al., 2003), indicating that CAPS-1
activity depended upon prior ATP-dependent priming functions selectively in DCV exocytosis.
during which PIP2 synthesis occurs. CAPS-1 activity In neuroendocrine PC12 cells, CAPS-1 acts at a late
and binding to the plasma membrane depended upon step in the DCV exocytic pathway after vesicle docking
PIP2. Ca2 was ineffective in triggering vesicle fusion (Walent et al., 1992; Hay and Martin, 1992; Ann et al.,
in the absence of CAPS-1 but instead promoted desen- 1997; Martin and Kowalchyk, 1997). CAPS-1 exhibits
sitization to CAPS-1 resulting from decreased plasma specific PIP2 binding in vitro, but the role of this propertymembrane PIP2. We conclude that CAPS-1 functions in CAPS-1 function has not been determined (Loyet et
following ATP-dependent priming as a PIP2 binding al., 1998; Grishanin et al., 2002). In addition, two mem-
protein to enhance Ca2-dependent DCV exocytosis.
brane-association domains in CAPS-1, a central pleck-
Essential prefusion steps in dense-core vesicle exo-
strin homology (PH) domain and a C-terminal region,cytosis involve sequential ATP-dependent synthesis
mediate plasma membrane and DCV associations, re-of PIP2 and the subsequent PIP2-dependent action of spectively, which suggests that CAPS-1 could bridgeCAPS-1. Regulation of PIP2 levels and CAPS-1 activity donor and acceptor membranes during DCV fusionwould control the secretion of neuropeptides and
(Grishanin et al., 2002). Studies of single exocytic eventsmonoaminergic transmitters.
in CAPS-1 antibody-injected chromaffin cells indicated
that CAPS-1 also regulates fusion pore dilation (Elham-Introduction
dani et al., 1999). The mechanism by which CAPS-1
functions and the precise point at which it acts relativeThe secretion of neurotransmitters and neuropeptides
to Ca2-triggered DCV fusion remain to be clarified.is mediated by the Ca2-triggered fusion of secretory
Ca2-triggered DCV exocytosis in PC12 cells exhibitsvesicles with the plasma membrane. Two classes of
relatively long latencies and slow rates compared tosecretory vesicles have been identified, small clear syn-
adrenal chromaffin cells (Ninomiya et al., 1997; Elham-aptic vesicles (SVs) and dense-core vesicles (DCVs) (De-
dani et al., 2000; Wang et al., 2001). In the current workCamilli and Jahn, 1990; Kelly, 1993), the contents, ori-
with PC12 cells, we found that recombinant CAPS-1gins, and functions of which are distinct. Exocytosis of
markedly increases the rate of a relatively slow ( 30the two vesicle types exhibits distinct regulation and is
s) Ca2-dependent step in DCV exocytosis that occurselicited by different patterns of stimulation (Jan and Jan,
after vesicle docking and ATP-dependent priming but1982; Matteoli et al., 1988; DeCamilli and Jahn, 1990;
prior to Ca2-triggered fusion. Ca2, acting in the ab-Verhage et al., 1991). Whereas rapid evoked SV exo-
sence of CAPS-1, was found to promote desensitizationcytosis is essential for fast synaptic transmission, DCV
to CAPS-1, and studies of desensitization indicated thatexocytosis is slower and mediates the release of trans-
it resulted from decreases in plasma membrane PIP2mitters that modulate pre- and postsynaptic events.
levels. Moreover, PIP2 was found to be essential forMechanisms for SV and DCV exocytosis utilize a number
of common components such as SNARE proteins, but CAPS-1 activity and binding to PC12 cell plasma mem-
there are constituents specific to either pathway that branes. The results indicate that CAPS-1 acts as a PIP2
may confer kinetic and regulatory properties distinct for binding protein that facilitates DCV exocytosis. Essential
each pathway (Rettig and Neher, 2002; Martin, 2003). prefusion steps in DCV exocytosis involve sequential
ATP-dependent synthesis of PIP2 and the subsequent
PIP2-dependent action of CAPS-1.*Correspondence: tfmartin@facstaff.wisc.edu
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Results protein. The nervous system dysfunction observed in
C. elegans unc-31 mutants (Avery et al., 1993; Ailion et
CAPS-1 Is Essential for Ca2-Dependent al., 1999) may be accounted for as a loss of modulatory
DCV Exocytosis transmitter secretion. We characterized loss-of-function
CAPS-1 increases the extent of Ca2-triggered DCV exo- mutant alleles of the C. elegans CAPS ortholog UNC-
cytosis in neuroendocrine cells by affecting a step be- 31p that result in uncoordinated locomotion. One of
yond DCV docking at the plasma membrane (Martin and the unc-31 mutant alleles contained a missense G538E
Kowalchyk, 1997). Multiple steps in the DCV pathway mutation in a predicted C2 domain of the UNC-31 protein
between docking and fusion have been inferred from (Figure 1E, right). We generated a rat protein with the
kinetic studies of Ca2-triggered exocytosis (Rettig and cognate G476E mutation and found that it was inactive
Neher, 2002), and it was unclear at which stage CAPS-1 in reconstituting Ca2-triggered NE secretion (Figure 1E,
is required. We utilized rotating disk electrode voltam- left). Moreover, it inhibited the low-level secretion elic-
metry with permeable PC12 cells (Earles et al., 2001) to ited by the addition of Ca2 alone (Figure 1E, left), similar
study the kinetics of Ca2-triggered norepinephrine (NE) to the inhibitory effect of CAPS-1 antibody (Figures 1B
release. DCV exocytosis is triggered by injection of Ca2, and 1C). This result suggested that the G476E protein
which mixes rapidly (50 ms) in the incubation chamber also had dominant-negative properties, which was con-
(Earles and Schenk, 1998). The method of cell permeabil- firmed by showing that a 4-fold molar excess of G476E
ization used (“cell cracking”) effectively extracts soluble protein inhibited the stimulation of secretion by wild-
proteins and renders DCV exocytosis dependent upon type CAPS-1 by 50% (Figure 1E, left). The loss-of-
added CAPS-1 (see below). The extent of Ca2-depen- function and dominant inhibitory properties of G476E
dent exocytosis is limited in the absence of CAPS-1 CAPS-1 detected in the permeable cell secretion assay
(Walent et al., 1992; Ann et al., 1997), so we compared provide a strong correlate to the in vivo nervous system
the kinetics of secretion reconstituted by added CAPS-1 dysfunction characterized for unc-31 loss-of-function
with those that proceed in its absence. CAPS-1 without mutant proteins (Avery et al., 1993; Ailion et al., 1999).
Ca2 did not promote NE release, and, in the absence
of CAPS-1, Ca2 evoked only a very small amount of CAPS-1 Functions at a Rate-Limiting Step
slow NE release (Figure 1A). In contrast, when CAPS-1 in Ca2-Triggered Exocytosis
was present, Ca2 injection elicited enhanced secretion The rates of DCV-mediated secretion triggered by Ca2
that exhibited faster kinetics with a 20-fold increase in rises in PC12 cells (Ninomiya et al., 1997; Elhamdani et
initial rates (Figure 1A). The activation of NE secretion al., 2000; Wang et al., 2001; Earles et al., 2001) are low
by CAPS-1 was completely blocked following treatment compared to the fastest components of DCV exocytosis
with botulinum neurotoxin E, which cleaves SNAP-25, observed in chromaffin and pituitary cells (Neher and
a plasma membrane SNARE protein required for DCV Zucker, 1993; Thomas et al., 1993; Heinemann et al.,
fusion (Figure 1B). 1993). We monitored rates of NE release in the perme-
While the majority of CAPS-1 is cytosolic in PC12 able PC12 cells directly in response to rapid Ca2 eleva-
cells and washed out of permeable cells, membrane- tions (to 20M Ca2f) at various CAPS-1 concentrations.associated CAPS-1 can be retained on DCVs (Berwin
The initial rates and final extent of Ca2-triggered exo-
et al., 1998; Grishanin et al., 2002). It was possible that
cytosis exhibited a strong dependence on CAPS-1 con-
the low level of NE release elicited by addition of Ca2
centration (Figure 2A). Following a short lag of 2–3 s,alone (Figure 1A, middle trace) was mediated by residual
progress curves could be fit by a single exponentialCAPS-1 in the permeable cells. This was found to be
function (Figure 2B) that we used to determine rate con-the case because affinity-purified IgGs from CAPS-1
stants for NE release. CAPS-1 substantially increasedantisera strongly reduced the extent of NE release trig-
the rate constant for Ca2-triggered exocytosis (Figuregered by addition of Ca2 alone (Figure 1C, dotted line).
2D) as well as the final extent of secretion (Figure 2C).CAPS-1 antibody reduced the rate of exocytosis trig-
At saturating CAPS-1 concentrations, the rate constantgered by Ca2 alone about 3-fold to close to the rate
for DCV exocytosis in permeable cells (k 0.025 s1;observed following botulinum neurotoxin E treatment
Figure 2D) was the same as that observed in intact PC12(Figure 1B, expanded ordinate). The strong dependence
cells following photolysis of caged Ca2 or depolariza-of Ca2-triggered exocytosis on CAPS-1 indicates that
tion (Ninomiya et al., 1997; Elhamdani et al., 2000; WangCAPS-1 functions at a late step through which most
et al., 2001).DCVs need to transit for Ca2-triggered fusion.
In previous reconstitution studies, CAPS-1 was shownPrevious studies identified an ATP-dependent priming
to affect the extent of Ca2-triggered secretion (Walentstep in DCV exocytosis that involves the synthesis of
et al., 1992; Ann et al., 1997), but these studies did notPIP2 (Hay and Martin, 1992; Hay et al., 1995). We found
resolve whether CAPS-1 acted prior to or in concert withthat CAPS-1 activity in Ca2-triggered NE release was
Ca2. If CAPS-1 and Ca2 acted at distinct sequentialnearly completely dependent upon prior ATP-depen-
steps leading to fusion, incubation with one of thesedent priming (Figure 1D). The role of the PIP2 synthesized
without the other might allow the accumulation of anduring ATP-dependent priming in CAPS-1 action is ad-
intermediate that would rapidly progress to fusion upondressed below. The results shown here together with
addition of the other. Injection of Ca2 alone elicitedprevious results (Martin and Kowalchyk, 1997) indicate
only low rates of exocytosis (Figure 2E, lower trace), butthat CAPS-1 functions in regulated exocytosis at a step
the subsequent addition of saturating CAPS-1 concen-following DCV docking and ATP-dependent priming.
trations elicited normal rates of secretion ( 29.5 s).The activity of CAPS-1 at this late step in DCV exo-
cytosis is likely to be a major physiological role for the When incubations were first conducted with saturating
CAPS Function in Exocytosis Requires PI(4,5)P2
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Figure 1. CAPS-1 Is Essential for Ca2-Trig-
gered DCV Exocytosis
(A) RDE voltammetry was used to detect NE
secretion from permeable PC12 cells elicited
by injection of 20 M Ca2f in the absence
(middle trace) or presence (upper trace) of 80
nM CAPS-1. CAPS-1 addition in the absence
of Ca2 did not elicit NE release (lower trace).
(B) Ca2-triggered NE release from perme-
able PC12 cells was determined in the ab-
sence of added CAPS-1 (upper trace), in the
presence of 320 nM IgG affinity purified from
CAPS-1 antisera (middle trace), or following
treatment with botulinum neurotoxin E (0.7 M
for 2 min prior to Ca2 injection, lower trace).
Arrow indicates delayed addition of 80 nM
CAPS-1.
(C) Inhibition of Ca2-dependent [3H]NE re-
lease from permeable PC12 cells by affinity-
purified IgGs from CAPS-1 antisera (closed
circle) or by IgGs from affinity column flow
through (closed square). Secretion was trig-
gered by 10 M Ca2 with 35 nM CAPS-1.
Affinity-purified IgGs suppressed secretion
below the level triggered by Ca2 in absence
of CAPS-1 (dotted line). Flow through IgGs
exerted similar inhibition with 10-fold re-
duced potency.
(D) Ca2-triggered NE release was deter-
mined in the presence of Ca2 alone (2 lower
traces) or in the presence of Ca2 with
CAPS-1 (2 upper traces) in permeable PC12
cells that were incubated with MgATP and
cytosol for 30 min (primed) or with Mg and
cytosol (unprimed) and washed. CAPS-1 acti-
vation of Ca2-dependent NE release was
highly dependent upon prior MgATP-depen-
dent priming.
(E) A recombinant G476E mutant rat CAPS-1
protein was generated as the cognate to a C. elegans G538E UNC31 mutant protein that exhibits full loss-of-function. Rat and C. elegans
proteins contain C2 and PH domains. The missense mutation is in the C2 domain (right panel). The G476E protein at 320 nM was inactive in
promoting Ca2-triggered NE release measured by RDE compared with wild-type CAPS-1 at 80 nM (left panel). The G476E protein at 320 nM
inhibited the activity of wild-type CAPS-1 at 80 nM, indicating that it possesses dominant-negative properties.
CAPS-1 concentrations (Figure 2E, upper trace), the de- tion, which indicates that the overall rate of exocytosis
in the permeable PC12 cells is determined by thelayed injection of Ca2 also elicited normal rates of se-
cretion (t 28.1 s). Similar results were obtained for CAPS-1- and Ca2-dependent step. The Ca2 depen-
dence of this step exhibited a Michaelis-Menten typethese order-of-addition studies when delay times for
the second addition were extended to several minutes. dependence (Figure 2F) showing no cooperativity for
Ca2 (n 1), which is in striking contrast to the highThese data fail to provide evidence for distinct sequen-
tial CAPS-1- and Ca2-dependent steps but instead sug- degree of cooperativity (n3) exhibited for fast compo-
nents of DCV exocytosis measured in chromaffin andgest that CAPS-1 acts at a step that also requires Ca2.
Alternatively, if CAPS-1 and Ca2 function at sequential pituitary cells (Thomas et al., 1993; Heinemann et al.,
1994). This indicates that the Ca2-dependent step atsteps, these steps must be highly dependent upon
each other. which CAPS-1 acts is unlikely to be the fusion step itself
but could correspond to a Ca2-dependent priming stepCAPS-1 binds Ca2 with low affinity (Ann et al., 1997)
and might contribute to the Ca2 sensitivity of secretion. previously characterized in chromaffin cells (Bittner and
Holz, 1992; von Ruden and Neher, 1993; Smith et al.,To assess this possibility, we studied the effects of
CAPS-1 on the Ca2 dependence of the rate constant 1998).
for exocytosis (Figure 2F). In agreement with previous
results (Earles et al., 2001; Kishimoto et al., 2001), Ca2 Mechanism by which CAPS-1 Regulates
the Extent of Secretionincreased the rate constant for DCV exocytosis with an
EC50 close to 10 M. CAPS-1 at three different concen- The preceding data showed that CAPS-1 regulates the
rate as well as the final extent of Ca2-triggered exo-trations did not affect the EC50 for Ca2 (Figure 2F). The
results exclude the possibility that CAPS-1 enhances cytosis in PC12 cells (Figures 2A, 2C, and 2D). An effect
of CAPS-1 solely on initial rates should not affect theexocytosis by increasing its sensitivity for activation by
Ca2. The maximal rate constant achieved at saturating final extent of secretion unless rates slowed during the
time course. A progressive slowing of rates could beCa2 was entirely dependent on the CAPS-1 concentra-
Neuron
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Figure 2. CAPS-1 Functions at a Rate-Lim-
iting, Ca2-Dependent Step of DCV Exo-
cytosis
(A) Ca2-triggered NE release from permeable
PC12 cells was detected by RDE at indicated
concentrations of CAPS-1. CAPS-1 was
added 1 min prior to the injection of 20 M
Ca2 at zero time.
(B) Kinetic parameters were derived from
RDE traces by fitting to a single exponential
equation shown for Ca2-triggered release at
1 M CAPS-1.
(C) The extent of NE release was dependent
on [CAPS-1].
(D) Rate constants for Ca2-dependent NE
release were dependent on [CAPS-1]. Rate
constants and extent of exocytosis were de-
rived by fitting to the exponential rise of a
maximum equation for RDE assays at 20 M
Ca2. Error bars represent the range of dupli-
cate determinations. EC50 values for CAPS-1
were determined using the Hill equation.
(E) The triggering of NE release from perme-
able PC12 cells requires the simultaneous
presence of CAPS-1 and Ca2. RDE determi-
nations of NE release were conducted in or-
der-of-addition experiments using 20 M
Ca2 and 700 nM CAPS-1. Upper trace:
CAPS-1 was added 10 s prior to Ca2 injec-
tion. Lower trace: Ca2 was injected 10 s prior
to CAPS-1 addition. Time constants indicated
on figure were derived from triplicate incuba-
tions (mean  SD).
(F) Rate constants for triggered NE release
are determined by Ca2 and CAPS-1 concen-
trations. RDE studies of NE release at various
Ca2 and CAPS-1 concentrations were con-
ducted to determine rate constants. CAPS-1
at 20 nM (open triangle), 80 nM (open circle),
and 200 nM (closed square) was added 1 min prior to Ca2 injection. EC50 values for Ca2 were derived from the Hill equation. [CAPS-1] did
not affect the EC50 for Ca2, but maximal rate constants at saturating [Ca2] were determined by [CAPS-1].
due to inactivation of CAPS-1 during the incubation, to supramaximal CAPS-1 concentrations (Figure 3C). In
this case, CAPS-1 addition at 0, 20, and 120 s followinga progressive desensitization of its effects, or to a more
general inactivation of the fusion machinery. Ca2 injection elicited indistinguishable increases in the
rates of exocytosis. Thus, supramaximal CAPS-1 con-To determine whether CAPS-1 underwent inactivation
during the incubation, we tested the effect of multiple centrations completely compensated for the apparent
desensitization observed in incubations with Ca2 alone.CAPS-1 injections during the incubation (Figure 3A). 20
nM CAPS-1 added after Ca2 elicited an expected in- By varying the CAPS-1 concentration in similar experi-
ments, it was clear that delay of CAPS-1 addition re-crease in exocytic rate, and addition of 10 nM CAPS-1
elicited a correspondingly smaller increase in the rate. sulted in desensitization that was characterized by an
increased EC50 for CAPS-1 (Figure 3D). These data elimi-However, the delayed injection of an additional 10 nM
CAPS-1 following the initial injection of 10 nM CAPS-1 nate the possibility that general inactivation or depletion
of the fusion machinery is responsible for the slowing ofprompted no further increase in the rate (Figure 3A).
These data indicate that CAPS-1 inactivation during the rates during the incubation and provide direct evidence
that desensitization to CAPS-1 is the basis for the pro-incubation was not responsible for the slowing of the
secretory rate but rather that desensitization was oc- gressive slowing of rates during the time course.
curring.
Ca2-dependent desensitization was further charac- Desensitization to CAPS-1 Results
from Reductions in PIP2terized at various CAPS-1 concentrations (Figure 3B).
The addition of submaximal CAPS-1 concentrations at In additional studies, we determined the time course for
the development of desensitization to CAPS-1 (Figureprogressively longer times following Ca2 resulted in
progressively reduced responses that were character- 4A). Desensitization was observed in the absence of
Ca2 but was markedly accelerated in the presence ofized by progressively increased time constants (from
  53.4 s to 139.2 s). To determine whether the slowing Ca2. We found that inclusion of MgATP abolished the
desensitization observed in the absence of Ca2 (notof rates during Ca2-triggered secretion was due to the
general inactivation of the fusion machinery or to a spe- shown). Desensitization induced by Ca2 was, however,
still observed in incubations containing MgATP (Figurecific desensitization to CAPS-1, we tested the effect of
CAPS Function in Exocytosis Requires PI(4,5)P2
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protein (Loyet et al., 1998; Grishanin et al., 2002), we
considered the possibility that decreases in PIP2 levels
were responsible for Ca2-induced desensitization to
CAPS-1. Either a Ca2-dependent phospholipase C
(Rhee, 2001) or a Ca2-activated phosphoinositide 5-phos-
phatase (Lee et al., 2004) could act to hydrolyze PIP2
and reduce CAPS-1 responsiveness. Indeed, we found
that addition of a recombinant Ca2-dependent phos-
pholipase C to incubations further reduced CAPS-1 re-
sponsiveness (Figure 4C) and promoted desensitization
with an increased EC50 for CAPS-1 (Figure 4D). These
data were consistent with the possibility that reductions
in PIP2 were responsible for Ca2-dependent desensiti-
zation to CAPS-1.
To directly assess plasma membrane PIP2 levels in
permeable PC12 cells, we utilized an immunocytochem-
ical assay with PIP2 antibody to quantitate plasma mem-
brane PIP2 levels (Aikawa and Martin, 2002). Cells that
were not primed with MgATP, which exhibit refractori-
ness for CAPS-1 activity (see Figure 1D), contained re-
duced levels of plasma membrane PIP2 compared to
cells primed with MgATP (Figures 4E and 4F). MgATP-
primed cells that were further incubated under condi-
tions that result in CAPS-1 desensitization (as in Figure
4A) exhibited decreases in plasma membrane PIP2 levels
that were accelerated in incubations containing Ca2
(Figure 4E). These data indicate that CAPS-1 activity in
DCV exocytosis correlates with plasma membrane PIP2
levels and that reductions in PIP2 levels could be respon-
sible for the decreased CAPS-1 activity observed in un-
primed cells or in cells that have undergone desensiti-
zation.
Previous studies documented that CAPS-1 is a PIP2
binding protein (Loyet et al., 1998; Grishanin et al., 2002).
To further assess the dependence of CAPS-1 function
on PIP2, we determined the requirements for CAPS-1
binding to PC12 cell membranes. Because little CAPS-1
Figure 3. Ca2 Induces a Progressive Desensitization of DCV Exo- remains associated with washed PC12 cell membranes,
cytosis to CAPS-1
we utilized a binding and wash protocol that would pre-
(A) NE secretion triggered by Ca2 addition was monitored by RDE. serve low-affinity binding. Concentration-dependent
20 nM CAPS-1 added 10 s after Ca2 injection promoted an in-
CAPS-1 binding was readily detected in permeablecreased rates of secretion (upper trace) and 10 nM CAPS-1 pro-
PC12 cells incubated with MgATP under priming condi-moted a correspondingly smaller increase in rate (lower trace). A
tions but was substantially reduced in unprimed cellssecond delayed addition of 10 nM CAPS-1 at 100 s after the first
addition elicited little or no increase in rates of secretion (lower (Figure 5A). This result suggests that a constituent im-
trace). portant for CAPS-1 membrane binding is produced in an
(B) Progressively delayed additions of 40 nM CAPS-1 following Ca2 ATP-dependent reaction. This constituent was shown to
injection resulted in progressively reduced increases in rates of be PIP2 or PIP by finding that treatment of ATP-primedsecretion. Secretion was triggered by the addition of 40 nM CAPS-1
permeable cells with a phospholipase C strongly re-at 0, 20, 120, and 220 s after 30 M Ca2 injection. Time constants
duced CAPS-1 binding (Figure 5B). To distinguishfor each response are indicated and showed a progressive increase.
whether the constituent required for binding was PIP2(C) Supramaximal CAPS-1 concentrations overcome Ca2-induced
desensitization. 800 nM CAPS-1 was added at 0, 20, and 120 s or PIP, we utilized a fusion protein corresponding to the
following injection of 20 M Ca2. Time constants for each response PH domain of phospholipase C	1 that selectively binds
are indicated showing that, in contrast to results in (B), no loss of PIP2 but not PIP (Rebecchi and Scarlata, 1998). Theresponsiveness occurred when high [CAPS-1] was used. PH domain protein strongly reduced CAPS-1 binding(D) RDE studies similar to those described for (B) were conducted
(Figure 5C) and correspondingly inhibited CAPS-1 activ-at indicated CAPS-1 concentrations with CAPS-1 added prior to
ity in secretion (not shown). These data indicate that PIP2Ca2 injection (closed square) or 120 s after Ca2 injection (closed
is essential for CAPS-1 binding to cellular membranes.circle). An experiment representative of three similar ones is shown.
Cells that had undergone Ca2-dependent desensitiza-
tion, which exhibit reduced levels of plasma membrane
4B). Because of the strong dependence of CAPS-1 activ- PIP2 (Figure 4E), were also found to exhibit reduced
ity upon MgATP-dependent priming (Figure 1D), the CAPS-1 binding (Figure 5D). Last, we utilized a fluores-
known importance of PIP2 synthesis in MgATP-depen- cent Alexa 488 CAPS-1 conjugate and found that bound
dent priming (Hay and Martin, 1992; Hay et al., 1995), CAPS-1 localized to the plasma membrane of ATP-
primed but not unprimed PC12 cells (Figure 5E). Theand the characterization of CAPS-1 as a PIP2 binding
Neuron
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Figure 4. Desensitization to CAPS-1 Is Medi-
ated by Decreased PIP2 Levels
(A) Time course for development of desensiti-
zation to CAPS-1. Primed permeable PC12
cells were incubated in the absence (open
circle) or presence (closed square) of Ca2
for the indicated times prior to 20 nM CAPS-1
injection. Relative rates of NE release deter-
mined by RDE are plotted on the ordinate.
Desensitization was observed in the absence
of Ca2 but was accelerated by Ca2.
(B) Ca2-dependent desensitization to CAPS-1
was observed in the presence of MgATP. 20
nM CAPS-1 was effective in promoting Ca2-
triggered NE release when added at zero time
but was highly attenuated when added 120 s
following Ca2 (arrow) whereas 200 nM
CAPS-1 was effective. RDE incubations were
conducted with 2 mM MgATP.
(C and D) Phospholipase C treatment induces
desensitization to CAPS-1.
(C) In RDE incubations with MgATP similar to
those of (B), 20 nM CAPS effectively pro-
moted Ca2-triggered NE release when
added at zero time or at 30 s (arrow) following
Ca2 (upper two traces) but was attenuated
when added at 30 s (arrow) to incubations
that included 1 M phospholipase C	1
(lower trace).
(D) Concentrations of CAPS-1 were varied in
incubations similar to those of (C) that lacked
(closed square) or contained (closed triangle)
phospholipase C	1. Phospholipase C treat-
ment increased the EC50 for CAPS-1. Figures
in (A)–(D) show results representative of three
similar experiments.
(E) Plasma membrane PIP2 levels in permeable PC12 cells were quantitated by immunocytochemistry with a PIP2 antibody. Permeable cells
were incubated in priming conditions with or without MgATP. MgATP-primed cells were further incubated for 3 or 6 min in the absence or
presence of Ca2 as described for (A). PIP2 levels are given in arbitrary units with means  SD (n  50; comparisons with MgATP condition
indicated significant differences, *p  .05, **p  .005).
(F) Representative images of PIP2 immunofluorescence in two permeable PC12 cells following priming incubations without or with MgATP.
results indicate that PIP2 is an essential coreceptor for rates of exocytosis 10 s after the addition of CAPS-1
antibody with rates 10 s after the addition of controlCAPS-1 plasma membrane binding.
IgG, we calculated an index of inhibition (Figure 6C),
which showed that Ca2-triggered secretion becameCAPS-1 Functions at a Prefusion Step
The preceding studies showed that CAPS-1 acts after progressively refractory to CAPS-1 antibody with in-
creasing delay time. This result suggests that during thean ATP-dependent priming step but they did not reveal
whether CAPS-1 functions at a late prefusion step or incubations, Ca2-triggered secretion progresses from
a CAPS-1-dependent to a CAPS-1-independent state.directly in DCV fusion. If CAPS-1 functioned directly in
a late fusion step, it should be possible to inhibit secre- Similarly, when we utilized the dominant-negative G476E
CAPS-1 protein to block DCV exocytosis, Ca2-triggeredtion at any point in the time course by inactivating
CAPS-1. If, in contrast, CAPS-1 functioned at an earlier secretion became progressively refractory to inhibition
with increasing time of delay (Figure 6C).step that preceded the final Ca2-triggered fusion step,
it may not be possible to inhibit secretion throughout The inhibitory effects of CAPS-1 antibody and G476E
CAPS-1 contrasted strongly with those of two otherthe time course by inhibiting CAPS-1 because DCVs
may progressively transit beyond the CAPS-1-depen- inhibitors of exocytosis. Addition of a VAMP2 cyto-
plasmic fusion protein as a dominant-negative inhibitordent step. To distinguish these possibilities, we inacti-
vated CAPS-1 by the addition of specific neutralizing of SNARE-dependent exocytosis was highly effective in
blocking secretion irrespective of its time of additionIgGs. Secretion was initiated with CAPS-1 added 1 min
prior to triggering with Ca2. With antibody introduced (Figures 6B and 6C). Addition of the Ca2 chelator EGTA
to reduce free Ca2 concentrations from 20 to 0.3 Mtogether with Ca2, inhibition was immediate and the
initial rate of exocytosis was reduced (Figure 6A). In was also highly effective in blocking secretion irrespec-
tive of its time of addition (Figure 6C). This is consistentcontrast, when CAPS-1 antibody addition was delayed
relative to Ca2 addition, the inhibition by antibody ex- with the requirement for Ca2 at a final Ca2-triggered
fusion step independent of any Ca2 requirements athibited slower onset and was reduced in extent (Figure
6A). There was a progressive attenuation of antibody earlier steps (von Ruden and Neher, 1993; Bittner and
Holz, 1992). The time courses for the indices of inhibitioninhibition with increasing delay time. By comparing the
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prefusion step, which is CAPS-1 dependent, and a
Ca2-dependent fusion step involving SNARE protein
function.
Discussion
CAPS-1 Functions as a Priming Factor
in DCV Exocytosis
A focus of the current work was to establish the execu-
tion point for CAPS-1 in the multistep sequential path-
way of DCV exocytosis. We conducted kinetic studies of
Ca2-triggered DCV exocytosis in a well-characterized
preparation of “cracked” PC12 cells (Walent et al., 1992;
Hay and Martin, 1992) where intracellular Ca2 rises can
be rapidly established in the chamber of a rotating disk
electrode (Earles et al., 2001). Our results reveal that
CAPS-1 is essential for a relatively slow, Ca2-depen-
dent step that rate limits DCV exocytosis in PC12 cells.
This step may correspond to a prefusion reaction termed
priming (Rettig and Neher, 2002) in which plasma mem-
brane-docked DCVs undergo conversion to a readily
releasable pool (RRP) from which Ca2 can rapidly trig-
ger fusion.
PC12 cells, derived from adrenal chromaffin cells,
have been widely utilized for studies of DCV exocytosis,
but the rates of Ca2-triggered secretion are quite low
with  values of 8,000–160,000 ms (Ninomiya et al.,
1997; Elhamdani et al., 2000; Wang et al., 2001; Earles
et al., 2001; Ng et al., 2002; Martin, 2003). In contrast,
the fastest capacitance rises detected for Ca2-trig-
gered DCV exocytosis in chromaffin and pituitary cells
Figure 5. CAPS-1 Binding to Plasma Membrane Requires PIP2 exhibit  values of 7–40 ms (Thomas et al., 1993; Heine-
CAPS-1 binding to permeable PC12 cells was conducted in (A)–(D) mann et al., 1993, 1994; Martin, 2003). This suggests
as described in Experimental Procedures. Each panel shows densi- that the rate-limiting step for Ca2-triggered DCV exo-
tometric quantitation of the Western blot for CAPS-1 shown in lower cytosis in PC12 cells differs from that in chromaffin or
portion. Results are representative of three similar studies.
pituitary cells. In nondifferentiated PC12 cells, initial fu-(A) CAPS-1 binding was strongly dependent upon prior MgATP-
sion events involve DCVs stably docked at the plasmadependent priming. Permeable cells were incubated under priming
membrane (Martin and Kowalchyk, 1997; Ng et al., 2002),conditions in the presence or absence of MgATP as indicated.
CAPS-1 concentration in binding incubation is indicated. which is also the case for DCVs in chromaffin and pitu-
(B) Binding of 25 nM CAPS-1 was reduced by treatment with phos- itary cells (Steyer et al., 1997). Thus, differences in the
pholipase C	1. MgATP-primed permeable cells were treated with rate-limiting step for Ca2-triggered DCV exocytosis ap-
phospholipase C	1 as in Figure 4C. Control binding in unprimed
pear to reside after DCV docking but before fusion.permeable cells is also shown.
Studies of Ca2-triggered membrane capacitance in-(C) The PH domain of phospholipase C	1 inhibits CAPS-1 binding.
creases in chromaffin cells characterized postdocking,Binding of 25 nM CAPS-1 to MgATP-primed permeable cells was
determined in the presence of indicated concentrations of the PH prefusion priming steps in DCV exocytosis. Multiple ki-
domain fusion protein. netic components of exocytosis elicited by Ca2 in-
(D) CAPS-1 binding is reduced under conditions of desensitization. creases consist of a rapid burst phase ( 0.03–0.3 s)
Binding of 25 nM CAPS-1 was determined for MgATP-primed per-
and a slower sustained phase (Voets et al., 1999; Voets,meable cells (none) that were further incubated under conditions of
2000). The burst component was interpreted as the fu-desensitization (see Figure 4A) without or with Ca2 for 6 min.
sion of a plasma membrane-localized RRP of DCVs that(E) Alexa 488 CAPS-1 binding to permeable cells preincubated with
or without MgATP. Bright punctate fluorescence at the plasma mem- undergoes rapid depletion upon repetitive or sustained
brane was detected for primed cells, whereas unprimed cells exhib- stimulation. The time-dependent replenishment of the
ited low level fluorescence on intracellular membranes. RRP, representing its refilling from a reserve pool of
docked unprimed DCVs, exhibits a time constant of
20–30 s (Gillis et al., 1996; Voets et al., 1999; Voets,by EGTA and VAMP2 fusion protein were strikingly dif-
ferent from those of CAPS-1 antibody and G476E 2000), which is10 times faster than rates of DCV dock-
ing (Steyer et al., 1997) and 100–1000 times slower thanCAPS-1 (Figure 6C). We interpret these results to indi-
cate that CAPS-1 initially acts at a step in DCV exo- the Ca2-triggered fusion of RRP vesicles (Thomas et
al., 1993; Heinemann et al., 1993, 1994). The rates ofcytosis prior to a final Ca2-triggered, SNARE-depen-
dent step of membrane fusion (Figure 6D). These results Ca2-triggered secretion that we measure in PC12 cells
( 30 s) are the same as the rates measured for RRPare consistent with evidence (Bittner and Holz, 1992;
von Ruden and Neher, 1993; Ashery et al., 2000) for at refilling in chromaffin cells. Refilling of the RRP in chro-
maffin cells was also reported to be Ca2 regulated (Bitt-least two Ca2-dependent steps in DCV exocytosis: a
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Figure 6. CAPS-1 Acts at a Step that Pre-
cedes the Final SNARE-Dependent Fusion
Step
(A) CAPS-1 antibody inhibition of Ca2-trig-
gered NE release from permeable PC12 cells
in response to triggering with 30M Ca2was
detected by RDE. 60 nM CAPS-1 was added
1 min prior to Ca2. 480 nM CAPS-1 immune
IgGs were added at the same time as Ca2
injection or added 20 or 50 s following Ca2
injection. CAPS-1 antibody added early but
not late was highly effective in blocking Ca2-
triggered NE secretion. The same concentra-
tion of affinity-depleted CAPS-1 IgGs exhib-
ited little inhibition (not shown).
(B) An RDE assay, conducted as in (A), tested
the effects of adding 35 M VAMP2 fusion
protein at the same time as Ca2 injection or
following 20 or 50 s delay.
(C) Ca2-triggered NE secretion becomes
progressively refractory to inhibition by
CAPS-1 immune IgGs and G476E CAPS-1 but
not to inhibition by EGTA or VAMP2 fusion
protein. An index of inhibition was calculated
from recordings similar to those of (A) and (B)
as 1  Vi/Vc, where Vi is the rate of secretion
measured 10 s after addition of inhibitor and
Vc is rate of secretion measured 10 s after
addition of vehicle or control antibody. 480 nM
CAPS-1 IgGs (closed square), 320 nM G476E
CAPS-1 (closed inverted triangle), 2 mM EGTA
(closed circle), and 35 M VAMP2 fusion pro-
tein (closed triangle) were tested.
(D) Proposed site of CAPS-1 action in DCV exocytosis. It is proposed that docked unprimed DCVs are converted in a two-step priming reaction
to a fully primed state. The first priming step is MgATP dependent and involves synthesis of PIP2. The second priming step is relatively slow
( 30 s) and is dependent upon Ca2 and CAPS-1, which binds PIP2. Following completion of MgATP-dependent priming, the second priming
step is rate-limiting for Ca2-triggered DCV exocytosis in PC12 cells. A Ca2-dependent mechanism (circular arrow) slows the rate of exocytosis
by promoting PIP2 hydrolysis and desensitization to CAPS-1. Completion of priming generates fully primed DCVs that undergo rapid ( 0.03–
0.3 s) fusion with the plasma membrane in a SNARE-dependent, Ca2-triggered process.
ner and Holz, 1992; von Ruden and Neher, 1993; Smith 1994) that is dependent upon SNARE complex formation
(Scales et al., 2000). Overall, the kinetics of Ca2-trig-et al., 1998) and to exhibit a Ca2 dependence that lacks
cooperativity, which contrasted with the highly coopera- gered secretion in PC12 cells can be accounted for by
a slow ( 30 s) CAPS-1-dependent, Ca2-dependenttive Ca2 dependence of RRP vesicle fusion (Heinemann
et al., 1993; Voets, 2000). Thus, the characteristics of priming step in which docked DCVs are converted into
an RRP that is short-lived and rapidly consumed in thethe rate-limiting step in PC12 cells are the same as those
for priming DCVs in chromaffin cells. Because CAPS-1 faster final Ca2-triggered fusion step (Figure 6D).
While the current studies suggest that CAPS-1 func-appears to function at this rate-limiting step, we suggest
that CAPS-1 is a priming factor for DCV exocytosis. tions at a prefusion step in DCV exocytosis, the molecu-
lar details of this step are poorly understood. Studies inEvidence that CAPS-1 acts at a step that precedes a
final Ca2-triggered fusion step was provided by studies chromaffin cells showed that CAPS-1 antibody strongly
reduced the number of fusion events but also altered thewith inhibitors that disrupt CAPS-1 function, which were
progressively ineffective when added at increasing de- kinetic properties of residual fusion events (Elhamdani et
al., 1999), suggesting a role for CAPS-1 in fusion porelay times following Ca2. While this suggests that DCVs
progressively transit beyond a CAPS-1-dependent step dilation. Further studies are needed to characterize
CAPS-1 interactions with proteins and lipids. CAPS-1during the incubations, we cannot eliminate the alterna-
tive interpretation that DCVs advance to a point where may function prior to fusion to promote assembly of
constituents that are required following DCV fusion toIgGs or G476E CAPS are sterically precluded from dis-
rupting CAPS-1 function. This interpretation, however, allow effective fusion pore formation or dilation.
implies that CAPS-1 accessibility changes in a distinct
manner prior to fusion, which identifies a unique initial CAPS-1 Functions as a PIP2 Binding Protein
Previous studies characterized a step between DCVexecution point for CAPS-1 prior to fusion. The results
with CAPS-1 disruption contrasted with those with the docking and fusion termed ATP-dependent priming
(Bittner and Holz, 1992; Hay and Martin, 1992), whichCa2 chelator EGTA or a VAMP2 cytoplasmic domain
fusion protein where immediate inhibition was observed involves the synthesis of PIP2 (Hay et al., 1995) and other
ATP-dependent processes (Banerjee et al., 1996; Bargirrespective of time of addition. These results are ex-
pected from the known Ca2 dependence of a final trig- et al., 2001). Priming of DCVs into the RRP in neuroendo-
crine cells was shown to require MgATP (Olsen et al.,gered fusion step (Thomas et al., 1993; Heinemann et al.,
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2003), whereas MgATP depletion was found to eliminate CAPS-1 (Grishanin et al., 2002). Current studies to iden-
the RRP of DCVs (Xu et al., 1998). However, the relation- tify the functionally important PIP2 binding domain in
ship of the ATP and Ca2 dependence of DCV priming CAPS-1 will enable direct mutagenesis studies to assess
reactions has been unclear (Bittner and Holz, 1992; von in greater detail the role of PIP2 binding in CAPS-1
Ruden and Neher, 1993; Smith et al., 1998). The present function.
results indicate that Ca2- and CAPS-1-dependent prim- Vesicle priming reactions are an important site for the
ing only occurs if ATP-dependent priming has gone to regulation of secretion because the size of the RRP is
completion (Figure 1D). Thus, the current studies further a critical determinant for rapid evoked transmitter or
define prefusion events in the DCV pathway as con- hormone release in response to Ca2 elevations. In addi-
sisting of two sequential priming steps, the first requiring tion, the rate of sustained secretion is determined by
MgATP and the second requiring Ca2 and CAPS-1 (Fig- the rate of vesicle priming after RRP vesicles have been
ure 6D). rapidly (1 s) depleted. Sustained rises in [Ca2] are
Previous studies showed that ATP-dependent priming known to elicit adaptive changes that depress rates
reactions involve the synthesis of PIP2, which is required of tonic secretion in neuroendocrine cells (Knight and
for Ca2-triggered DCV exocytosis (Hay and Martin, Baker, 1982; Van der Merwe et al., 1990; Jones et al.,
1992; Hay et al., 1995; Holz et al., 2000), but the precise 1992), but the mechanism for adaptation was unknown.
role of PIP2 in exocytosis has not been defined. A general Sustained [Ca2] rises in permeable PC12 cells resulted
role for PIP2 in cellular processes is to recruit PIP2 bind- in transiently increased rates of secretion that exhibited
ing proteins to specific locations in the plasma mem- progressive slowing. Our data indicate that the slowing
brane (Martin, 2001). Several PIP2 binding proteins that of rates was due to CAPS-1 desensitization, which re-
may function in regulated exocytosis have been identi- sulted from reductions in plasma membrane PIP2 pools.
fied including CAPS-1 (Loyet et al., 1998; Grishanin et Several Ca2-dependent mechanisms that hydrolyze
al., 2002), synaptotagmin (Schiavo et al., 1996; Tucker PIP2, including Ca2-dependent phospholipase C (Rhee,
et al., 2003; Bai et al., 2004), rabphilin (Chung et al., 2001) and calcineurin-activated phosphoinositide phos-
1998), and Mints (Okamoto and Sudhof, 1997), but the phatase (Lee et al., 2004), could mediate the Ca2-
role of PIP2 binding in the function of these proteins is dependent desensitization that depresses DCV exo-
largely unknown. The current work indicates that PIP2 cytic rates.
synthesized during MgATP-dependent priming is an es- Conversely, increases in PIP2 synthesis have been
sential cofactor for CAPS-1 function. We found that shown to enhance rates of DCV priming. PI 4-kinase,
PC12 cells with reduced plasma membrane PIP2 levels the first lipid kinase required for PIP2 synthesis from PI,
exhibited reduced responsiveness to CAPS-1. Modest is regulated by cellular ADP levels. This was shown to
reductions in PIP2 levels reduced secretory rates but serve as a metabolic sensor in pancreatic 
 cells that
could be functionally compensated for by elevated con- mediates glucose-induced PIP2 synthesis and DCV
centrations of CAPS-1. Such results suggest that PIP2 priming (Olsen et al., 2003). PI(4)P 5-kinase, the second
functions as a plasma membrane coreceptor for CAPS-1. lipid kinase required for PIP2 synthesis from PI, is regu-
Direct binding studies with CAPS-1 further indicated lated by a protein kinase C-mediated pathway that leads
that its plasma membrane binding was strongly depen- to increased plasma membrane PIP2 levels and en-
dent upon PIP2. These results link the characterized hanced sustained rates of DCV exocytosis (Aikawa and
in vitro PIP2 binding properties of CAPS-1 (Loyet et al., Martin, 2002). As an essential PIP2 effector protein, it is
1998; Grishanin et al., 2002) to the function of CAPS-1 expected that the modulation of CAPS-1 levels or activ-
in DCV exocytosis. Consistent with our results, recent ity would also regulate rates of secretion by affecting
studies in pancreatic 
 cells showed that ATP-depen- the Ca2-dependent priming of DCVs.
dent DCV priming could be by-passed by directly sup- In summary, we present evidence that CAPS-1 func-
plying PIP2 and that CAPS-1 was required for a vesicle tions at a prefusion step in DCV exocytosis that is rate
priming step that follows the PIP2-requiring step (Olsen limiting for secretion in PC12 and possibly other neuro-
et al., 2003).
endocrine cells that lack a stable RRP of DCVs (SewardThe exact role of PIP2 binding in CAPS-1 function et al., 1995) or when secretion is sustained. The CAPS-1-remains to be clarified. Presumably, interactions with
dependent step follows ATP-dependent priming, duringPIP2 mediate CAPS-1 recruitment to specific plasma which synthesis of PIP2 occurs, which is required formembrane domains where DCV fusion occurs. Because
CAPS-1 activity as a PIP2 binding protein. CAPS-1-CAPS-1 is also a resident protein on DCVs (Berwin et
dependent priming may be an important site for regula-al., 1998; Grishanin et al., 2002), CAPS-1 recruitment to
tion that would control rates of neuropeptide and mono-plasma membrane PIP2 could increase the association
amine transmitter secretion.of DCVs with the plasma membrane. CAPS-1 undergoes
a concerted conformational change upon PIP2 binding
(Loyet et al., 1998), and this may function as a switch Experimental Procedures
to alter CAPS-1 interactions with other constituents. The
Secretion Assaysfunctionally important PIP2 binding site in CAPS-1 re-
PC12 cells (clone 2-6) were cultured as described (Klenchin et al.,mains to be identified. While all CAPS proteins contain
1998). For the RDE voltammetric analysis of catecholamine secre-a central PH domain, a structural module that mediates
tion, cells were incubated with 1.5 mM NE and 0.5 mM ascorbate
phosphoinositide interactions in some proteins (Rebec- for 16–24 hr. Cells were washed and detached from dishes and
chi and Scarlata, 1998), our previous studies showed permeabilized by passage through a ball homogenizer. Washed
that the PH domain is essential for CAPS-1 function permeable cells were incubated for 30 min at 30C in priming reac-
tions with rat brain cytosol and MgATP as described previouslybut that it was not the principal PIP2 binding domain in
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(Klenchin et al., 1998). This ATP-dependent priming incubation was CAPS-1 proteins (Grishanin et al., 2002) were expressed in SF-9
insect cells using a baculovirus expression vector. Insect cells in-omitted where indicated. Primed permeable cells were washed 2–3
times prior to resuspension in KGlu buffer (0.02 M HEPES [pH 7.2], fected with baculovirus were harvested 48 hr after infection in phos-
phate-buffered saline (PBS) with 0.005 M EDTA, washed into PBS,0.12 K glutamate, 0.02 M K acetate, 0.002 M EGTA).
Catecholamine release was detected by RDE voltammetry in 350 and homogenized in a glass dounce homogenizer in PBS containing
0.1% Tween-20, 10 g/ml aprotinin, 10 g/ml leupeptin, and 0.001l reactions containing 107 permeable cells incubated at 35C in a
water-jacketed glass chamber that contained an Ag/AgCl reference M PMSF. The homogenate was centrifuged at 80,000  g, and
the supernatant was applied to a column of Ni-NTA Sepharose.and platinum auxiliary electrode (Earles and Schenk, 1998). A 3 mm
glassy carbon disk electrode held in a precision rotator was placed Following washes with 10 column volumes of lysis buffer, 50 column
volumes with lysis buffer lacking detergent, and 10 column volumesinto the cell suspension and rotated at 3000 rpm to maintain rapid
mixing conditions. A potentiostat was used to apply a potential to of 0.01 M imidazole (pH 7.6), 0.25 M NaCl, 10% v/v ethylene glycol,
the column was eluted with 0.15 M imidazole (pH 7.6), 0.25 M NaCl.the electrode of 500 mV relative to the Ag/AgCl reference elec-
trode, and the output was processed by using a Tektronix recording Elution buffer was replaced with KGlu by buffer exchange on a PD-
10 column (Amersham Pharmacia Biotech). Rabbit antibodies wereoscilloscope or a Dataq analog to digital data acquisition system.
Catecholamine release was triggered by rapid injection of Ca2 via generated to recombinant CAPS-1 and purified by conventional
methods employing chromatography on protein A-Sepharose (Phar-a spring-loaded Hamilton syringe. Total catecholamine content of
the cells was obtained by injection of Triton X-100 to 0.1%. macia) and affinity columns of CAPS-1 immobilized on Bio-Gel 15
(Bio-Rad Laboratories).With optimal CAPS-1 in Ca2 triggering reactions, 40% NE re-
lease corresponding to the exocytosis of 400 DCVs/cell was ob-
served. We estimate that release corresponding to the exocytosis UNC-31p/CAPS Mutant Characterization
of 10 or fewer DCVs/cell would be readily detected by our assays. The C. elegans CB714 strain harboring the e714 unc-31 loss-of-
In some assays, we increased cell density to improve detection function allele, generously provided by J. Hodgkin, was grown by
to exocytosis of 1 DCV/cell and were unable to detect kinetic standard techniques for preparation of poly(A) RNA (Krause, 1995).
components faster than those reported in the text. Various precondi- RT-PCR was used to generate four amplicons spanning the 4106
tioning studies with Ca2 subthreshold for triggering exocytosis also nt coding sequences of UNC-31 mRNA. Standard ABI Prism Dye
failed to detect more rapid components. Calibrations of release Termination Cycle sequencing reactions were conducted, which
curves were conducted by injecting stock solutions of NE. Release identified a single nucleotide substitution (G→A) that changed a
curves were background subtracted to eliminate slight signal drops GGA codon (glycine) to GAA (glutamate) corresponding to amino
due to addition of Ca2. Corrected curves were fit by a single expo- acid 538. To introduce the cognate G476E mutation in the rat
nential function (see Figure 2B) using Microcal Origin software (Mi- CAPS-1 protein, a fragment corresponding to nucleotides 1170–
crocal Software) and used to obtain time constants and amplitudes 2458 of the coding sequence of the full-length rat CAPS-1 cDNA was
of response. Rates of secretion were derived from the first deriva- amplified by PCR and cloned into the SmaI site of the pBluescript II
tives calculated from the release curves. KS(-) vector. The construct was used as a template for site-directed
The extent of secretion was also monitored with an assay that mutagenesis using the Quick Change protocol (Stratagene). The
detects the release of [3H]NE as previously described (Klenchin et fragment was sequenced and then digested with AflII and Eco47-
al., 1998). PC12 cells were labeled with 0.5Ci/ml [3H]NE (Amersham III for insertion into the AflII and Eco47-III site in place of the corre-
Pharmacia Biotech) plus 0.5 mM sodium ascorbate for 16 hr at 37C. sponding wild-type fragment. The full-length insert was excised with
A two-stage assay with MgATP-primed permeable cells (Klenchin PmeI and subcloned into the StuI-cleaved pFastBac1 donor plasmid
et al., 1998) was used to determine the Ca2-triggered release of to prepare recombinant baculoviruses (GIBCO-BRL).
[3H]NE in 3 min incubations at 30C. Results are plotted as percent
[3H]NE release by normalization to the total content of [3H]NE per in- Acknowledgments
cubation.
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